LifePoint Health (NASDAQ:LPNT) has been given a consensus recommendation of “Hold” by the twenty-two analysts that are covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, eleven have given a hold recommendation, six have given a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $53.77.
Several research firms have recently commented on LPNT. SunTrust Banks restated a “hold” rating and set a $58.00 price target on shares of LifePoint Health in a research report on Monday, May 7th. BidaskClub upgraded shares of LifePoint Health from a “buy” rating to a “strong-buy” rating in a research report on Friday, May 4th. Wolfe Research upgraded shares of LifePoint Health from an “underperform” rating to a “peer perform” rating in a research report on Friday, March 16th. Cantor Fitzgerald restated a “hold” rating and set a $50.00 price target on shares of LifePoint Health in a research report on Friday, February 23rd. Finally, Mizuho reiterated a “hold” rating and issued a $51.00 target price on shares of LifePoint Health in a research report on Thursday, March 22nd.
In related news, Chairman William F. Carpenter III bought 21,368 shares of the firm’s stock in a transaction that occurred on Wednesday, February 28th. The stock was purchased at an average price of $46.80 per share, for a total transaction of $1,000,022.40. Following the transaction, the chairman now directly owns 482,668 shares of the company’s stock, valued at approximately $22,588,862.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 8.80% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the business. Alliancebernstein L.P. lifted its holdings in LifePoint Health by 1.7% in the 4th quarter. Alliancebernstein L.P. now owns 1,762,076 shares of the company’s stock valued at $87,751,000 after acquiring an additional 28,721 shares during the last quarter. Boston Partners lifted its holdings in LifePoint Health by 50.8% in the 4th quarter. Boston Partners now owns 874,690 shares of the company’s stock valued at $43,559,000 after acquiring an additional 294,480 shares during the last quarter. Stone Ridge Asset Management LLC acquired a new stake in LifePoint Health in the 4th quarter valued at about $326,000. First Trust Advisors LP lifted its holdings in LifePoint Health by 33.4% in the 4th quarter. First Trust Advisors LP now owns 414,248 shares of the company’s stock valued at $20,630,000 after acquiring an additional 103,680 shares during the last quarter. Finally, OppenheimerFunds Inc. lifted its holdings in LifePoint Health by 24.1% in the 4th quarter. OppenheimerFunds Inc. now owns 37,099 shares of the company’s stock valued at $1,848,000 after acquiring an additional 7,203 shares during the last quarter.
Shares of LifePoint Health stock traded down $0.10 during trading on Friday, hitting $55.25. 394,102 shares of the stock were exchanged, compared to its average volume of 449,228. The firm has a market capitalization of $2.14 billion, a P/E ratio of 15.22, a P/E/G ratio of 1.46 and a beta of 0.50. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.55 and a current ratio of 1.76. LifePoint Health has a 12 month low of $41.45 and a 12 month high of $67.95.
LifePoint Health (NASDAQ:LPNT) last released its quarterly earnings results on Friday, May 4th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.13 by $0.09. The business had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.62 billion. LifePoint Health had a net margin of 0.48% and a return on equity of 6.56%. The company’s quarterly revenue was down 1.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.07 earnings per share. sell-side analysts forecast that LifePoint Health will post 4.3 earnings per share for the current year.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.